References
- Pui CH, Robison LL, Look AT. Acute lymphoblastic leukemia. Lancet 2008;371:1030–1043.
- Simone J, Aur RJ, Hustu HO, et al. “Total therapy” studies of acute lymphocytic leukemia in children. Current results and prospects for cure. Cancer 1972;30:1488–1494.
- Rivera GK, Pinkel D, Simone JV, et al. Treatment of acute lymphoblastic leukemia. 30 years’ experience at St. Jude Children's Research Hospital. N Engl J Med 1993;329:1289–1295.
- Riehm H, Feickert HJ, Schrappe M, et al. Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis. Haematol Blood Transfus 1987;30:139–146.
- Gustafsson G, Kreuger A, Clausen N, et al. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: The Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatr 1998;87:1151–1161.
- Moricke A, Zimmermann M, Reiter A, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010;24:265–284.
- Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM study group. Blood 2000;95:3310–3322.
- Steinherz PG, Redner A, Steinherz L, et al. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Cancer 1993;72:3120–3130.
- Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007;370:240–250.
- Stary J, Zimmermann M, Campbell M, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol 2014;32:174–184.
- Giebel S, Labopin M, Ehninger G, et al. Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia. Blood 2010;116:122–128.
- Silla L, Fischer GB, Paz A, et al. Patient socioeconomic status as a prognostic factor for ALLO-SCT. Bone Marrow Transplant 2009; 43:571–577.
- Pui CH, Pei D, Sandlund JT, et al. Long-term results of St Jude Total Therapy Studies 11, 12, 13a, 13b, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2010;24:371–382.
- Radwanska U, Michalewska D, Kaczmarek M, et al. Why our ALL-treatment results in children do not reach the BFM-level? Symposium on Children Oncology. Wroclaw, Poland, May 24-27, 1989. Prace Naukowe AM Wroclaw 1990;22(Suppl.);67–73.
- Boguslawska-Jaworska J. Pediatric hematology in Poland: past and present. Pediatr Hematol Oncol 1994;11:243–250.